Arrowstreet Capital, Limited Partnership Celldex Therapeutics, Inc. Put Options Transaction History
Arrowstreet Capital, Limited Partnership
- $122 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CLDX
# of Institutions
194Shares Held
64.9MCall Options Held
1.65MPut Options Held
973K-
Wellington Management Group LLP Boston, MA8.98MShares$200 Million0.04% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$104 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.88MShares$86.4 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.46MShares$77 Million9.64% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$74.2 Million1.99% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.04B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...